We are thus underestimating the extent of mutated signaling in tumor cells caused by other mechanisms, for example genomic deletions such as the EGFRvIII isoform in glioblastoma, or translocations such as BCR-ABL in leukemia. The gene discussed is ABL1; the disease is glioblastoma.